Friday – Clinical Track 5A Survey

Name Badge ID(Required)

Full Name(Required)

Enter your first and last names as you would like them to appear on your certificates.

First Last

Email(Required)

Enter the email you used to register for TOXINS 2022.

Please evaluate the speakers

Overall Evaluation

Topic and Speaker(s)

	Excellent	Good	Fair	Poor
Pretarsal or orbital injections? The art of eyelid watching and prevention and management of side effects post injection Bettina Wabbels, MD (Germany)
Challenges in the treatment of Meige syndrome Marie-Helene Marion, MD (UK)
Treatment of blepharospasm in progressive supranuclear palsy with botulinumtoxin: A retrospective comparative study Lejla Paracka, MD (Germany)
Botulinum neurotoxin treatment combined with motor learning exercises for Pisa syndrome in Parkinson’s disease – a case study Anna Castagna, MD (Italy)

Presentation free of commercial bias?

	Yes	No
Pretarsal or orbital injections? The art of eyelid watching and prevention and management of side effects post injection Bettina Wabbels, MD (Germany)
Challenges in the treatment of Meige syndrome Marie-Helene Marion, MD (UK)
Treatment of blepharospasm in progressive supranuclear palsy with botulinumtoxin: A retrospective comparative study Lejla Paracka, MD (Germany)
Botulinum neurotoxin treatment combined with motor learning exercises for Pisa syndrome in Parkinson’s disease – a case study Anna Castagna, MD (Italy)

If you answered “No, this presentation was not free of commercial bias”, on any of the above, please explain your reason(s).

Applicable to my practice/research

	Yes	No
Pretarsal or orbital injections? The art of eyelid watching and prevention and management of side effects post injection Bettina Wabbels, MD (Germany)
Challenges in the treatment of Meige syndrome Marie-Helene Marion, MD (UK)
Treatment of blepharospasm in progressive supranuclear palsy with botulinumtoxin: A retrospective comparative study Lejla Paracka, MD (Germany)
Botulinum neurotoxin treatment combined with motor learning exercises for Pisa syndrome in Parkinson’s disease – a case study Anna Castagna, MD (Italy)

This activity should improve my

	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care

Comments